This is a video synopsis/summary of an Insights involving Eric D. Donnenfeld, MD. The best way ophthalmologists and optometrists can work with payers to ensure access to the important new ...
This is a video synopsis/summary of an Insights involving Eric D. Donnenfeld, MD. Demodex is a very common eyelash mite found in most USpatients, causing blepharitis and inflammation. Many clinicians ...
The treatment of blepharitis focuses on alleviating symptoms, addressing underlying causes, and preventing complications. [iStockphotos] Blepharitis is a common chronic condition that affects the ...
Red eyes can be caused by mild problems like contact overuse and eye strain — or more serious issues like glaucoma or uveitis ...
Demodex blepharitis impacts approximately 25 million eye care patients in the U.S. – or 1 out of every 12 adults. XDEMVY is indicated for all adult patients with Demodex blepharitis and is available ...
Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced the initiation of the Mississippi trial, a Phase 2b clinical trial of NCX 4251, evaluating ...
Q: I have a condition called blepharitis. Nothing seems to help. Would you please give me some information on this problem and what I can do about it? A: Since I don't know what you've tried, I can't ...
IRVINE, Calif., July 25, 2023 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize ...
Welcome to the Mite Party. In its latest effort to raise awareness about demodex blepharitis, an eye condition that affects 25 million Americans, Tarsus Pharmaceuticals is throwing a party — a Mite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback